FIELD: medicine.
SUBSTANCE: immunological analysis and general blood test are carried out. In blood TNF-α, absolute content of CD4+lymphocytes, relative content of T-cytotoxic lymphocytes CD8+, results of spontaneous NBT-test are determined, in blood serum - general complementary activity, and Y index is calculated by formula. If Y value is less than 4.6, non-proliferative version of uterine myoma is predicted, if Y is higher than 6.8, proliferating version of uterine myoma is predicted; if Y is from 4.6 to 6.8 prognosis is indefinite, it is necessary to apply method of descriptive statistics (use of qualitative anamnestic and clinical criteria).
EFFECT: increased accuracy and informativity of diagnostics of morphological versions of uterine myoma in women of reproductive age.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE OF LEIOMYOMA GROWTH PATTERNS | 2013 |
|
RU2542468C1 |
| METHOD FOR PREDICTING THE PROBABILITY OF DEVELOPMENT OF PROLIFERATING UTERUS MYOMA | 2018 |
|
RU2676035C1 |
| METHOD FOR PREDICTING THE EFFECTIVENESS OF TREATING UTERINE FIBROIDS USING FUS-MRI ABLATION IN THE PATIENTS OF REPRODUCTIVE AGE AT THE STAGE OF PREGNANCY PLANNING | 2019 |
|
RU2716337C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR UTERUS LEIOMYOMA GROWTH TYPE | 2008 |
|
RU2361216C1 |
| METHOD FOR PREDICTING GROWTH RATE OF UTERINE LEIOMYOMA IN WOMEN OF REPRODUCTIVE AGE | 2018 |
|
RU2690379C1 |
| METHOD FOR PREDICTION OF UTERINE LEIOMYOMA NECROSIS IN PREGNANT WOMEN IN THEIR SECOND TRIMESTER | 2010 |
|
RU2436092C1 |
| METHOD FOR PREDICTING THE PRESENCE OF SARCOMA IN WOMEN WITH PROLIFERATING UTERINE MYOMA | 2018 |
|
RU2682801C1 |
| METHOD FOR PREDICTING UTERINE LEIOMYOMA SIZE INCREASE | 2019 |
|
RU2704819C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF CERVICAL INTRAEPITHELIAL NEOPLASIA OF GRADE III AND MICROINVASIVE CERVICAL CANCER ASSOCIATED WITH HUMAN PAPILLOMA VIRUS | 2019 |
|
RU2735660C1 |
| METHOD FOR ONCOLOGICAL DISEASES COURSE PREDICTION | 2016 |
|
RU2622756C1 |
